12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Reshape Lifesciences (RSLS) led the gainers with a 22.3% increase, while NextCure (NXTC) saw the largest drop among the losers, falling 19.3%. Other notable gainers included Esperion Therapeutics (ESPR), Femasys (FEMY), Bio-Path Holdings (BPTH), Codexis (CDXS), and Akso Health Group (AHG). On the losing side, Apellis Pharmaceuticals (APLS), Ocular Therapeutix (OCUL), Pasithea Therapeutics (KTTA), Monte Rosa Therapeutics (GLUE), and Assure Holdings (IONM) also saw their stock prices decline.
December 14, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Esperion Therapeutics shares increased by 21.85% to $1.84 with a market cap of $209.2 million.
The substantial pre-market rise in ESPR stock price could indicate a positive short-term momentum due to investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Reshape Lifesciences stock jumped 22.3% in pre-market trading with a market cap of $6.1 million.
The significant pre-market increase in RSLS stock price suggests positive investor sentiment which could lead to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Apellis Pharmaceuticals shares fell 14.13% to $54.0 with a market cap of $6.3 billion.
The pre-market decrease in APLS stock price suggests a negative outlook that may continue in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
NextCure shares dropped 19.3% in pre-market trading with a market cap of $32.6 million.
The pre-market decline in NXTC stock price indicates negative investor sentiment, likely leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100